仿制药市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00006393
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 152
Buy Now

2018年肿瘤仿制药市场价值为212亿美元,预计到2027年将达到360.296亿美元;预计 2019 年至 2027 年复合年增长率为 6.3%。

医疗保健中的仿制药是使用机器学习算法和软件来分析、处理和呈现复杂的医疗和保健数据。它已被广泛用于支持临床决策、改进工作流程和预测健康结果。因此,人工智能在医疗保健领域的广泛应用可能会推动市场的增长。仿制药市场的增长归因于全球癌症患病率的增加,仿制药的上市和仿制药提供的好处可能会促进市场增长,而癌症的个性化医疗可能会倾向于是未来几年的普遍趋势。

仿制药市场预计在大流行后将出现大幅增长。由于封锁、旅行禁令和企业关闭,COVID-19 已经影响了各国的经济和行业。 COVID-19 危机使许多国家的公共卫生系统负担过重,凸显了对卫生系统可持续投资的强烈需求。随着 COVID-19 大流行的进展,医疗保健行业的增长预计将下降。由于体外诊断产品需求的增加以及全球研发活动的增加,生命科学领域蓬勃发展。然而,由于进行的手术数量减少以及设备采购推迟或延长,医疗技术和成像领域的销售额正在下降。此外,医疗保健专业人员的虚拟咨询预计将成为大流行后的主流护理服务模式。随着远程医疗改变医疗服务方式,数字医疗将在未来几年继续蓬勃发展。此外,临床试验的中断以及随后药物上市的延迟预计也将为未来的完全虚拟试验铺平道路。 mRNA 等新技术预计将出现并改变制药行业,未来几年市场预计还将出现更多的垂直整合和合资企业。

利润丰厚的地区肿瘤仿制药市场

市场洞察

肿瘤仿制药在医疗保健领域的应用不断增长,推动肿瘤仿制药市场增长

癌症是全球主要死亡原因之一,极大地影响生活质量。因此,癌症如果不及时诊断和治疗,将会给社会带来负担。根据世界卫生组织 2018 年的数据,全球约有 960 万人死于癌症。此外,美国国家癌症研究所预测,2018年美国将诊断出约1,735,350例新癌症病例。

此外,癌症在欧洲国家也很常见以及。根据英国癌症研究中心的数据,2016 年,英国约有 163,444 人死于癌症。

此外,亚太地区还面临着癌症患病率不断上升的问题。癌症患病率排名前 15 位的国家/地区是:日本、台湾、新加坡、韩国、马来西亚、泰国、中国、菲律宾、斯里兰卡、越南、印度尼西亚、蒙古、印度、老挝和柬埔寨。根据国家癌症预防和研究所 (NICPR) 的数据,2018 年,印度因癌症死亡的总人数为 784,821 人。

这些统计数据表明全球各个地区对先进癌症诊断的需求不断增加。从而推动预测期内仿制药肿瘤药物的增长。

仿制药癌症药物市场是由频繁的药物上市推动的。大多数主要市场参与者都参与制造各种有助于降低癌症治疗成本的仿制药癌症药物。例如,2019 年 7 月,Lupin Pharmaceuticals, Inc. 推出了一款用于治疗某些类型癌症的仿制药甲磺酸伊马替尼片剂。

此外,2019 年 4 月,印度领先制药公司 Emcure Pharmaceuticals 推出了世界上第一个用于治疗转移性乳腺癌的仿制药艾日布林。

Emcure 正在销售品牌名为“Eribilin”的药物,该药物为印度乳腺癌患者提供高质量且具有成本效益的治疗选择。药物 Eribilin 是卫材制药的过期专利产品的仿制药。

此外,2019年1月,Hetero Healthcare Ltd推出了一款新仿制药拉帕替尼片剂,在印度用于治疗转移性乳腺癌。这些药片与卡培他滨或来曲唑一起服用,共同抑制患者癌细胞的生长。因此,仿制药的不断发展加速了预测期内的市场增长。

仿制药是品牌药的复制品。它们的药理作用与品牌同类产品相似。

仿制药具有成本效益,因为制造商没有投资于新药的开发和营销。

当药物专利到期时,其他制造商会申请 FDA 批准才能制造和销售该产品。因此,仿制药比品牌药便宜。仿制药与原研药具有完全相同的功效、剂量、副作用、给药途径、安全性、风险和强度。

仿制药在肿瘤学中很重要,因为一些抗癌药物仅作为仿制药提供。在大多数情况下,患有急性淋巴细胞白血病的儿童或患有早期乳腺癌的女性患者都接受仿制药治疗。仿制药广泛用于支持治疗。使用仿制药最显着的好处是成本,比品牌药低 85%。


基于分子类型的见解

就术语而言从分子类型来看,仿制药市场分为大分子、小分子。 2018年,按分子类型划分,小分子细分市场占有最大的市场份额,占肿瘤仿制药市场的87.67%。

按分子类型划分的仿制药肿瘤药物市场– 2018年和2027年


基于适应症的见解

根据适应症,仿制药市场细分为肺癌、胃癌、结直肠癌、乳腺癌、前列腺癌、肝癌、肾癌、宫颈癌等。 2018年,从迹象来看,肺癌细分市场占据了最大的市场份额。

战略见解

仿制药市场参与者是采用产品推出和扩张策略来满足全球不断变化的客户需求,这也使他们能够在全球范围内维持其品牌名称。

仿制药肿瘤药物市场 –按分子类型

  • 大分子
  • 小分子

仿制药市场按适应症

  • 肺癌
  • 胃癌
  • 结直肠癌
  • 乳腺癌
  • 前列腺癌
  • 肝癌
  • 肾癌
  • 宫颈癌
  • 其他

仿制药市场–按地理位置

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • < li>欧洲
    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 休息欧洲
  • 亚太地区 (APAC)
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和非洲非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲 (SCAM)
    • 巴西
    • 阿根廷
    • 其他 SCAM
  • < /ul>

    公司简介

    • Teva Pharmaceutical Industries LTD.
    • Sandoz International GMBH
    • Glenmark制药有限公司
    • Sun Pharmaceutical Industries LTD
    • MSN Laboratories
    • Aurobindo Pharma
    • Intas Pharmaceuticals LTD
    • Zydus Cadila
    • Mylan NV
    • Shilpa Medicare LTD
    • Fresenius Kabi AG
    • Dr.雷迪实验室。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies - Generic Oncology Drugs Market

  1. Teva Pharmaceutical Industries Ltd.
  2. Sandoz International GMBH
  3. Glenmark
  4. Sun Pharmaceutical Industries Ltd
  5. MSN Laboratories
  6. Aurobindo Pharma
  7. Intas Pharmaceuticals
  8. Zydus Cadila
  9. Mylan N.V.
  10. Cipla Inc.
  11. Fresenius Kabi AG
  12. Dr. Reddy’s Laboratories Ltd.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports